Takeda fy2020 h1 results demonstrate portfolio resilience; confirms full-year management guidance & raises forecasts for free cash flow, reported op & reported eps

Osaka, japan--(business wire)--takeda pharmaceutical company limited (tse:4502/nyse:tak) (“takeda”) today announced financial results for the first half of fiscal year 2020 (period ended september 30, 2020). takeda president & chief executive officer christophe weber commented: “takeda's performance in the first half of fy2020 demonstrates the resilience of our business model, the depth of our portfolio and the commitment of our employees, who continue to serve patients and communities glob
TAK Ratings Summary
TAK Quant Ranking